Amazing News! Pharem & Zymatic have been awarded 400kEUR funding from Swedish Energy Agency. The EU´s Urban Wastewater Treatment Directives (UWWTD) also want WWTPs to strive for net neutrality. Technologies with low energy consumption, such as Zymatic, will play a key-part for this to be possible. #zymatic #micropollutants #swedishenergyagency #enzymes #impact #sustainability
Pharem welcomes Jula Holding as owner in the ongoing series A financing round. Jula Miljö & Energi, a part of Jula Holding, takes a substantial lead position and aims to close the round in the coming months.
Pharem have successfully increased their portfolio of customer related projects, both in the Nordic countries but also internationally. To accelerate these projects Pharem have been granted financing from Nefco.
We proudly announce that Pharem, with its technology Zymatic, has been awarded the Solution of the Year in the #AcceliCITY Resilience Challengas 2021! With Zymatic, Pharem creates affordable solutions for treatment of micropollutants originating from society. #impact #sustainability #enzymes #watertreatment #leadingcities
Lonza Solutions and Pharem Biotech have started a new water treatment project together. Using Zymatic, Pharem's enzyme treatment technology, the treatment step will be tailored to target and treat various organic compounds in one or more selected process streams.
The aim of the collaboration between the two companies is to extend the existing technology range for treatment of organic micro-pollutants through Pharem´s modern enzyme technology. The joint focus will primarily be towards wastewater treatment plants (WWTP:s) on the Nordic market.
The water treatment technology, Pharem Filtration System (PFS), has been selected in hard competition by the Dutch knowledge centre STOWA*. The organisation is jointly owned by the regional water managers in the country and will evaluate the system that have been developed towards municipal wastewater treatment plants (WWTP)
